Theravance Biopharma, Inc.

TBPHNasdaq· Pharmaceutical Preparations

Price History

Revenue

$107.5M

▲ 66.9% YoY

Net Income

$105.9M

▲ 287.7% YoY

EPS

$2.06

▲ 279.1% YoY

Cash

$167.8M

▲ 344.0% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.